IVC Filter Issues (Vena Cava Filter Implantation) is a procedure to place a filter device in the inferior vena cava. IVC Filter placement has been associated with many complications.
The inferior vena cava is the large vein that returns blood from the lower body to the heart. The device is a filter that traps blood clots in the lower body. This prevents the clots from traveling to the lungs. If you have experienced any serious complications of this filter, call us now!
Studies show 1 out of 4 IVC filters fracture, potentially causing death
IVC Filter Issues risks and possible complications include:
- Bleeding or infection at the catheter insertion site
- Filter may break
- Damage to the vein used for the procedure
- Problems due to contrast fluid, like an allergic reaction or kidney damage
- Incorrect placement of the filter
- Filter may become clogged with clots and block blood flow, which may cause severe leg swelling
- Filter may loosen, change location, or float to another location in the body, like the heart or lungs
- Risks of anesthesia or other medicines used during the procedure
The FDA has issued a Safety Communication update for Inferior Vena Cava Filters (“IVC Filters”). If you have been implanted with an IVC Filter, which is a medical device sometimes placed in patients at risk for a pulmonary embolism, you may wish to see a doctor for health purposes, and speak with an attorney to evaluate your legal options.
The safety and efficacy of IVC filters have been well documented. Nevertheless, various complications associated with these filters have been described, and early diagnosis and management are the keys to reducing patient morbidity and mortality.
Regrettably, the increased use of the devices have also resulted in increased concern over potential complications. Accounts given report of perforation, migration and filter fractures have posed serious adverse events for some patients. The greater number of complications have involved migration of the device, where the filter moves to other areas of the body.
FREE CASE EVALUATION
The Food & Drug Administration (FDA) has received reports of adverse events and serious problems associated with IVC filters. Types of reports include device migration, filter fracture, embolization (movement of the entire filter or fracture fragments to the heart or lungs), perforation of the IVC, and difficulty removing the device. Some of these events led to dire clinical outcomes. These types of events may be related to how long the filter has been implanted and the type. Other known long-term issues associated with IVC filters included lower limb deep vein thrombosis and IVC occlusion. For patients with retrievable filters, some complications may be avoided if the filter can be removed once the risk of pulmonary embolism has subsided.